• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

当代生物标志物在慢性酒精使用检测中的应用。

Use of contemporary biomarkers in the detection of chronic alcohol use.

作者信息

Montalto Norman J, Bean Pamela

机构信息

Department of Family Medicine, West Virginia University School of Medicine, Charleston, WV, U.S.A.

出版信息

Med Sci Monit. 2003 Dec;9(12):RA285-90.

PMID:14646983
Abstract

Alcohol is the most commonly abused substance yet alcoholism is frequently undiagnosed. The misuse of alcohol is common and frequently an occult problem. More than 10% of current drinkers meet diagnostic criteria for alcohol abuse or dependence while the lifetime prevalence for these conditions in outpatient settings ranges from 16 to 36 percent. Long-term, heavy drinking is associated with significant morbidity, mortality, and economic costs. Clues to alcohol use can be discovered from a patient's history and physical stigmata. Validated screening instruments such as the Alcohol Use Disorders Identification Test (AUDIT), CAGE Questionnaire, and Brief Michigan Alcoholism Screening Tests help confirm the clinical suspicion of alcohol dependence. Laboratory abnormalities of mean corpuscular volume, gamma-glutamyl transferase, alkaline phosphatase, or alanine amino transferase levels are non-specific indicators of possible alcohol-induced liver impairment. Newer, less well-known FDA-approved biochemical markers such as the Carbohydrate Deficient Transferrin and the Early Detection of Alcohol Consumption test may also be used to detect heavy alcohol abuse and to monitor relapse episodes. Brief interventions are successful, making identification and diagnosis a vital role for the family physician. Improved awareness of alcohol misuse, increased use of screening tools, and the appropriate use of biochemical markers will facilitate early intervention and successful management of patients with alcohol use disorders.

摘要

酒精是最常被滥用的物质,但酒精中毒却常常未被诊断出来。酒精的滥用很常见,而且往往是个隐匿的问题。超过10%的当前饮酒者符合酒精滥用或依赖的诊断标准,而在门诊环境中,这些情况的终生患病率在16%至36%之间。长期大量饮酒会导致显著的发病率、死亡率和经济成本。可以从患者的病史和身体特征中发现饮酒的线索。经过验证的筛查工具,如酒精使用障碍识别测试(AUDIT)、CAGE问卷和密歇根酒精ism筛查简表,有助于确认对酒精依赖的临床怀疑。平均红细胞体积、γ-谷氨酰转移酶、碱性磷酸酶或丙氨酸氨基转移酶水平的实验室异常是可能由酒精引起的肝损伤的非特异性指标。更新的、鲜为人知的经美国食品药品监督管理局(FDA)批准的生化标志物,如缺糖转铁蛋白和酒精消费早期检测测试,也可用于检测重度酒精滥用并监测复发情况。简短干预是有效的,这使得识别和诊断对家庭医生至关重要。提高对酒精滥用的认识、增加筛查工具的使用以及合理使用生化标志物将有助于对酒精使用障碍患者进行早期干预和成功管理。

相似文献

1
Use of contemporary biomarkers in the detection of chronic alcohol use.当代生物标志物在慢性酒精使用检测中的应用。
Med Sci Monit. 2003 Dec;9(12):RA285-90.
2
Validity of carbohydrate-deficient transferrin (%CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin.碳水化合物缺乏转铁蛋白(%CDT)、γ-谷氨酰转移酶(γ-GT)和平均红细胞体积(MCV)作为慢性酒精滥用生物标志物的有效性:一项针对酒精依赖患者以及非酒精性和酒精性肝病患者的研究
Addiction. 2005 Oct;100(10):1477-86. doi: 10.1111/j.1360-0443.2005.01216.x.
3
Comparison of new alcohol use test, the Helsinki Alcohol Use Test questionnaire, and Alcohol Use Disorders Identification Test and laboratory markers serum gamma-glutamyl transferase and carbohydrate-deficient transferrin.新型酒精使用测试、赫尔辛基酒精使用测试问卷、酒精使用障碍识别测试以及实验室指标血清γ-谷氨酰转移酶和缺糖转铁蛋白的比较。
Addict Behav. 2004 Jun;29(4):717-22. doi: 10.1016/j.addbeh.2004.02.001.
4
Recognition of alcohol and substance abuse.
Am Fam Physician. 2003 Apr 1;67(7):1529-32.
5
[The diagnostic validity of screening tests and laboratory markers in alcohol use disorders].[酒精使用障碍筛查试验和实验室标志物的诊断效度]
Turk Psikiyatri Derg. 2005 Spring;16(1):3-12.
6
Screening trauma patients with the alcohol use disorders identification test and biomarkers of alcohol use.使用酒精使用障碍识别测试和酒精使用生物标志物对创伤患者进行筛查。
Alcohol Clin Exp Res. 2009 Jun;33(6):970-6. doi: 10.1111/j.1530-0277.2009.00917.x. Epub 2009 Mar 19.
7
Detection of alcohol abuse in neurological patients: variables of clinical relevance to the accuracy of the %CDT-TIA and CDTect methods.神经科患者酒精滥用的检测:与%CDT-TIA和CDTect方法准确性相关的临床变量。
Alcohol Clin Exp Res. 2001 Jan;25(1):46-53.
8
Objective diagnosis of alcohol abuse: compared values of carbohydrate-deficient transferrin (CDT), gamma-glutamyl transferase (GGT), and mean corpuscular volume (MCV).酒精滥用的客观诊断:比较碳水化合物缺乏转铁蛋白(CDT)、γ-谷氨酰转移酶(GGT)和平均红细胞体积(MCV)的值。
Alcohol Clin Exp Res. 2000 Sep;24(9):1414-9.
9
Are biomarkers of chronic alcohol misuse useful in the assessment of DWI recidivism status?慢性酒精滥用的生物标志物是否可用于评估 DWI 累犯状态?
Accid Anal Prev. 2010 Jan;42(1):307-12. doi: 10.1016/j.aap.2009.08.016. Epub 2009 Sep 19.
10
Use of laboratory markers and the audit questionnaire by primary care physicians to detect alcohol abuse by patients.初级保健医生使用实验室指标和审核问卷来检测患者的酒精滥用情况。
Alcohol Alcohol. 2005 Nov-Dec;40(6):520-3. doi: 10.1093/alcalc/agh219.

引用本文的文献

1
Iron and iron-related proteins in alcohol consumers: cellular and clinical aspects.酒精消费者体内的铁和铁相关蛋白:细胞和临床方面。
J Mol Med (Berl). 2022 Dec;100(12):1673-1689. doi: 10.1007/s00109-022-02254-8. Epub 2022 Oct 10.
2
Development and validation of a composite score for excessive alcohol use screening.过量饮酒筛查综合评分的开发与验证
J Investig Med. 2016 Jun;64(5):1006-11. doi: 10.1136/jim-2015-000033. Epub 2016 Mar 21.
3
Proteomic approaches and identification of novel therapeutic targets for alcoholism.
蛋白质组学方法与酒精中毒新治疗靶点的鉴定
Neuropsychopharmacology. 2014 Jan;39(1):104-30. doi: 10.1038/npp.2013.182. Epub 2013 Jul 31.
4
Evaluation of cell proliferation, apoptosis, and DNA-repair genes as potential biomarkers for ethanol-induced CNS alterations.评估细胞增殖、凋亡和 DNA 修复基因作为乙醇诱导的中枢神经系统改变的潜在生物标志物。
BMC Neurosci. 2012 Oct 25;13:128. doi: 10.1186/1471-2202-13-128.
5
IGF-I and IGFBP-3 before and after inpatient alcohol detoxification in alcohol-dependent subjects.酒精依赖患者住院酒精戒断前后的 IGF-I 和 IGFBP-3。
Med Sci Monit. 2011 Oct;17(10):CR547-51. doi: 10.12659/msm.881979.
6
Ethanol consumption: how should we measure it? Achieving consilience between human and animal phenotypes.乙醇摄入:我们应该如何测量它?在人类和动物表型之间实现一致。
Addict Biol. 2010 Apr;15(2):109-24. doi: 10.1111/j.1369-1600.2009.00192.x.
7
Alcohol history and smoking cessation in nicotine replacement therapy, bupropion sustained release and varenicline trials: a review.尼古丁替代疗法、安非他酮缓释片和伐尼克兰试验中的饮酒史与戒烟:一项综述
Alcohol Alcohol. 2007 May-Jun;42(3):196-206. doi: 10.1093/alcalc/agm022.